The collaboration brings together Sandoz expertise in launching and commercializing treatments with Pear's leading experience in digital therapeutics design and implementation. Sandoz and Pear will work together to
Catabasis is prioritizing this program to deliver against its goal of bringing a life changing therapy to those affected by Duchenne. Catabasis CEO Jill Milne said: “This decision
The company's five-year commitment to the fight against malaria was announced in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonwealth
Unigreg owns the rights to Forceval, a micro-nutrient supplement used in pregnancy, in China and some nearby territories. Alliance will continue to market the Forceval brand in the
EMPA-KIDNEY will investigate the effects of empagliflozin on the progression of kidney disease and the occurrence of cardiovascular death, in people with established chronic kidney disease with and
The company has determined that additional investments of time and resources in these programs are not appropriate given the other opportunities in its product development pipeline. The terminated
Study results showed KEYTRUDA significantly prolonged recurrence-free survival (RFS), reducing the risk of disease recurrence or death by 43% compared to placebo in the overall study population (HR=0.57
The investment bolsters the company’s Canadian operations and its commitment to advancing public health around the world. The announcement will be made during an event today at Sanofi
CEPI will fund up to $56m to support Inovio’s pre-clinical and clinical advancement through Phase 2 of INO-4500, its Lassa fever vaccine, and INO-4700, its MERS vaccine. The shared
Under the agreement, GSK will receive a 19.9% stake in Orchard and get a seat on its board. The acquisition of the portfolio, which includes both approved and investigational therapies
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.